<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The aim of this cross-sectional study was to document the clinical management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and related complications in Canada's First Nations </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Patients were randomly selected from 19 communities </plain></SENT>
<SENT sid="2" pm="."><plain>Data from charts from consenting patients were collected </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of 885 patients, 63.3% were female, mean age was 54.9 years and mean duration of T2DM was 11.2 years </plain></SENT>
<SENT sid="4" pm="."><plain>Mean A1C was 8.2%; 61.1% of patients had an A1C &gt;7.0%; mean <z:chebi fb="15" ids="39026">LDL</z:chebi> was 2.4 mmol/L; 92.6% had <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>; mean systolic BP was 132 mm Hg; mean diastolic BP was 76 mm Hg; 92.0% had <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="23" ids="18059">Lipid</z:chebi>-lowering medications were prescribed to 62.9% of those with <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> and an <z:chebi fb="0" ids="47774">LDL-C</z:chebi> &gt;2.0 mmol/L </plain></SENT>
<SENT sid="6" pm="."><plain>Of hypertensive patients, 15.8% were not on an <z:chebi fb="0" ids="35674">antihypertensive agent</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>For vascular protection, 55.1% were on a <z:chebi fb="0" ids="35664">statin</z:chebi>, 72.1% on an <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi> or ARB, and 64.5% on an <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Smoking was documented in 39.4%, 92.1% were overweight/<z:mp ids='MP_0001261'>obese</z:mp>; 55.1% had <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e>, and 13.3% had <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Major care gaps were revealed, with most patients not achieving glycemic, <z:chebi fb="23" ids="18059">lipid</z:chebi> and BP targets </plain></SENT>
<SENT sid="10" pm="."><plain>Over half of this relatively young cohort had established microvascular disease </plain></SENT>
<SENT sid="11" pm="."><plain>Macrovascular disease rates may increase dramatically due to the high prevalence of risk factors </plain></SENT>
</text></document>